Orchard Capital Managment, LLC Heron Therapeutics, Inc. Transaction History

Orchard Capital Managment, LLC

$111 Million
Q3 2025

A detailed history of Orchard Capital Managment, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Orchard Capital Managment, LLC holds 677,290 shares of HRTX stock, worth $745,019. This represents 0.78% of its overall portfolio holdings.

Number of Shares

677,290

Previous 659,933 2.63%

Holding current value

$745,019

Previous $1.37 Million 36.6%

% of portfolio

0.78%

Previous 1.56%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$1.21 - $2.23 $21,001 - $38,706	17,357 Added 2.63%	677,290 $866,000
Q2 2025 Aug 13, 2025	SELL	$1.72 - $2.42 $1.33 Million - $1.87 Million	-771,825 Reduced 53.91%	659,933 $1.37 Million
Q1 2025 May 15, 2025	SELL	$1.47 - $2.55 $653,711 - $1.13 Million	-444,702 Reduced 23.7%	1,431,758 $3.15 Million
Q4 2024 Feb 14, 2025	SELL	$1.06 - $2.12 $109,962 - $219,924	-103,738 Reduced 5.24%	1,876,460 $2.87 Million
Q3 2024 Nov 13, 2024	SELL	$1.73 - $3.67 $455,384 - $966,046	-263,228 Reduced 11.73%	1,980,198 $3.94 Million

Q2 2024 Aug 13, 2024	SELL	$2.32 - $3.86 $66,020 - $109,844	-28,457 Reduced 1.25%	2,243,426 $7.85 Million
Q1 2024 May 14, 2024	BUY	$1.71 - $3.06 $48,661 - $87,078	28,457 Added 1.27%	2,271,883 $6.29 Million
Q4 2023 Feb 14, 2024	BUY	$0.54 - $1.82 $54,325 - $183,097	100,603 Added 4.69%	2,243,426 $3.81 Million
Q3 2023 Nov 14, 2023	BUY	$0.97 - $1.8 $729,190 - $1.35 Million	751,743 Added 54.04%	2,142,823 $2.21 Million
Q2 2023 Sep 01, 2023	SELL	$1.11 - $2.88 $1.39 Million - $3.6 Million	-1,251,123 Reduced 47.35%	1,391,080 $1.61 Million
Q2 2023 Aug 14, 2023	BUY	$1.11 - $2.88 $1.39 Million - $3.6 Million	1,251,123 Added 89.94%	2,642,203 $3.06 Million
Q3 2022 Nov 15, 2022	BUY	$2.66 - $5.37 $971,048 - $1.96 Million	365,056 Added 35.58%	1,391,080 $5.87 Million
Q2 2022 Aug 15, 2022	BUY	$2.3 - $6.29 $135,930 - $371,739	59,100 Added 6.11%	1,026,024 $2.85 Million
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $2.78 Million - $5.97 Million	600,920 Added 164.18%	966,924 $5.53 Million
Q4 2021 Feb 15, 2022	BUY	$8.35 - $12.6 $59,285 - $89,460	7,100 Added 1.98%	366,004 $3.34 Million
Q2 2021 Aug 17, 2021	BUY	$13.27 - $18.48 $4.76 Million - $6.63 Million	358,904 New	358,904 $5.57 Million

Others Institutions Holding HRTX

# of Institutions

188

Shares Held

151M

Call Options Held

20.1K

Put Options Held

2.12M

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $131M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orchard Capital Managment, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orchard Capital Managment, LLC with notifications on news.

Account

Orchard Capital Managment, LLC Heron Therapeutics, Inc. Transaction History